Investrend Update Available for RVP Investrend has released a July update on Retractable Technologies Inc., including information relating to recent contracts signed by the company. Investors may view the update online at http://216.234.225.2/external.asp?b=577&id=135&from=pi For security purposes, investors may be asked to log in through the Investor Pass system. After following
Retractable Technologies Signs Agreements to Market VanishPoint® Safety Needle Devices to the Benelux Countries, Denmark and Sweden LITTLE ELM, Texas—In a major milestone in its global marketing strategy, Retractable Technologies, Inc. (AMEX: RVP), a leading maker of safety needle devices, announced today that it has signed marketing agreements with three
Retractable Technologies Signs Agreement to Produce VanishPoint® Safety Syringes in China for Global Market LITTLE ELM, Texas, June 24, 2002—Retractable Technologies, Inc. (AMEX: RVP), a leading maker of safety needle devices, announced today that it has signed a long-term agreement with Double Dove Co., Ltd., the largest syringe maker in
New York Times: A Mission to Save Money, a Record of Otherwise The New York Times has published a new article in its ongoing MEDICINES’S MIDDLEMEN series examining hospital purchasing contracts. You may view the entire article online at http://www.nytimes.com/2002/06/07/business/07BUYE.html?ex=1024467054&ei=1&en=c028e05097b50dd7 A Mission to Save Money, a Record of Otherwise June
Letter to Shareholders Dated May 31, 2002 The attached Adobe PDF document is a letter to shareholders dated May 31, 2002. Due to a technical error in the Yahoo! Finance system that has delayed posting, some followers of Retractable Technologies may not have seen this letter. The document may also
Centers for Disease Control Selects VanishPoint (R) Safety Needle Devices for Anthrax Vaccine Study LITTLE ELM, Texas, May 22, 2002—Retractable Technologies, Inc. (AMEX: RVP), a leading maker of safety needle devices, announced today that the Centers for Disease Control (CDC) has selected its VanishPoint® automated retraction 3cc syringe and blood
Investrend Research Update on Retractable Technologies: Q1, 2002 Results In-Line With Expectations May 15, 2002–Investrend Research Analyst Justin Canivet issued a research update today on Retractable Technologies (AMEX: RVP), reiterating his strong buy rating. He cited a 12-month price target of $11.00 per share for RVP stock. The full text
RETRACTABLE TECHNOLOGIES, INC. ANNOUNCES TWENTY PERCENT REVENUE INCREASE FOR THREE MONTHS ENDED MARCH 31, 2002 LITTLE ELM, Texas, May 9, 2002— Retractable Technologies, Inc. (AMEX: RVP) (“Retractable”) a leading maker of safety needle devices, today reported increased sales for the three months ended March 31, 2002. Net revenues for the
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders LITTLE ELM, Texas – (BW HealthWire) – April 30, 2002 – Thomas J. Shaw, President and CEO of Retractable Technologies, Inc. (AMEX:RVP – news), a leading maker of safety syringes and blood collection devices, today
Investrend Research Announces Investment Opinion: Retractable Technologies `Strong Buy,’ $11.00 12 Mo Target Issued by Investrend Analyst Justin Canivet, CFA NEW YORK–(BUSINESS WIRE)–April 17, 2002–Investrend analyst Justin Canivet has reiterated a ‘Strong Buy’ and 12 month target of $11.00 on Retractable Technologies (AMEX:RVP). The full report is available at http://www.investrend.com.